Clinical trial: randomized study of clarithromycin versus placebo in active Crohn’s disease

Abstract

Clarithromycin 1 g for 3 months is ineffective in active Crohn's disease but possible benefit was observed at 1 month, suggesting that an initial effect may be attenuated by subsequent bacterial resistance.